Frost & Sullivan’s Top 10 predictions for healthcare in 2021

From vaccines to virtual care, enterprise imaging to precision medicine, these are the growth areas that will shape the direction of healthcare, this year and beyond.

The year 2020 has been a year unlike any other year in our history. It has impacted the fabric of our society and life – but most importantly it has changed the healthcare industry forever.

The following 10 predictions that we have made for the global healthcare will define new ways of rethinking business and growth opportunities in 2021, and will help determine the future direction of the industry.

1. By the end of 2021, about 4 billion COVID-19 vaccine doses will be delivered globally.

These will be prioritized to immunize three target groups: the healthcare workforce, consisting of service providers, management & support workers in hospitals and social care; adults above 65; and about 45% of adults with comorbidities.

More than 50% of the expected production capacity of the vaccine candidates, which are in Phase III and are getting emergency approval, have been pre-booked by developed economies, such as the U.S., the E.U., Japan, Canada and the U.K.

Developing low- and middle-income countries are relying primarily on COVAX, the vaccines pillar of the Access to COVID-19 Tools Accelerator, which is co-led by the Coalition for Epidemic Preparedness Innovations, GAVI, the Vaccine Alliance and the World Health Organization. These organizations aim to deliver two billion doses by the end of 2021 equitably among all the 172 participating countries, which would result in around 25% of the global population getting vaccinated.

Pharmaceutical companies will be collaborating extensively for manufacturing, supply chain requirements, post-surveillance studies and storage. Digital enterprise vaccination management platforms will have to be built to inform the public, schedule vaccinations, automate mobile facilities, monitor outcomes and manage the supply chain for COVID-19 vaccines.

By Reenita Das | Healthcare IT News

Image Credit: Reenita Das / Healthcare IT News

READ MORE

About Peter Coffaro 610 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the orthopedic industry. Recognized by MedReps.com and the World Journal of Orthopedics as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager and Distributor. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy and Stryker. He is also the founder of OrthoFeed: a popular blog that covers orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing and professional education. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.